Lumibird Medical - Quantel Medical, Ellex & Optotek

💧 Many thanks to Dr Rolando Toyos, MD for his valuable contribution to the FacoFest 2024 congress, held in Mexico City from 24 to 26 October. Dr Toyos shared his insights on the crucial role of diagnosing and treating Dry Eye Disease prior to ocular surgeries, especially cataract and refractive procedures. We are honored to see our CDIAG and CSTIM devices making a real difference in enhancing patient outcomes by ensuring accurate diagnosis and effective dry eye treatment. #DryEyeDisease #Ophthalmology #CDIAG #CSTIM #LumibirdMedical

🌟 𝗣𝗮𝘁𝗶𝗲𝗻𝘁-𝗖𝗲𝗻𝘁𝗿𝗶𝗰: 𝗢𝘂𝗿 𝗰𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁 𝘁𝗼 𝘆𝗼𝘂 At Lumibird Medical, the patient shapes everything we do: patient needs and well-being are at the heart of our decision-making process. 👥 Our global network of Key Opinion Leaders (KOLs) is an integral part of this approach. We actively collaborate with them to push the boundaries of healthcare, ensuring that our products are constantly evolving to meet the real needs of patients. 📊 With over 30 clinical trials underway, including 4 major trials, led by our Medical Director, Professor Mario de La Torre, we don't just talk about putting patients first, we live it. These studies are key to improving patient care across the board. 📚 To enhance the capabilities of healthcare professionals, we also create personalised materials for patients. These resources help patients better understand their condition, promoting confidence, knowledge and an easier journey to better health. At Lumibird Medical, being patient-centric isn't just a value, it's a promise to the people whose lives we strive to improve every day. 🙌 #Patient #Ophthalmology #Innovation #LumibirdMedical

✨ Lumibird Medical is proud to announce the nomination of Quantel Medical for the INPI France Trophies 2024 - Export Category! The INPI Trophies celebrate companies that exemplify innovation in France, particularly through their outstanding intellectual property strategies. Being nominated in the Export category is a true honor, as it recognizes our efforts in bringing our innovations to international markets, our dedication to innovation and our strategy in terms of intellectual property. Our commitment to innovation is reflected in concrete results: nearly 30 patents family fields and the launch of several new products each year.  These achievements testify to the richness of our R&D projects and our determination to offer cutting-edge solutions to improve patient care around the world. The winners will be announced on November 27th – stay tuned! A big thank you to all our teams, partners, and customers who contribute to our success every day. Let's continue to innovate and expand together! #INPITrophies #Innovation #Export #IntellectualProperty #QuantelMedical

Thanks to our ABSolu ultrasound platform, it is easier than ever to obtain detailed and accurate images of ocular structures, enabling optimal treatment planning. More information here: https://lnkd.in/eavPPkwd #ABSolu #ultrasound #lumibirdmedical #ophthalmology

🎇 That's a wrap on AAO 2024 in Chicago! The Lumibird Medical USA team had an incredible time showcasing our latest innovations and performing live demonstrations at the AAO - American Academy of Ophthalmology Annual Meeting. We were thrilled to welcome so many visitors to our booth and host insightful presentations by esteemed physicians. 👏 A huge thank you to everyone who attended and participated in our sessions: ▪️ “Advanced Imaging and Diagnostic Aid” with Dr. Rolando Toyos, MD ▪️ “ICL with STS” with Dr. Brett Mueller, D.O., Ph.D., & Dr. Taj Nasser, MD ▪️ “Versatility with the ABSolu” with Prof. Mario Danilo de La Torre Estremadoyro & Beth Parrish, CDOS, ROUB, COA It was an honor to connect with so many professionals and share our passion for advancing ophthalmology! Stay tuned for more updates and innovations from Lumibird Medical. #AAO2024 #Ophthalmology #LumibirdMedical

📊 𝗣𝗥𝗘𝗦𝗦 𝗥𝗘𝗟𝗘𝗔𝗦𝗘 - Q3 REVENUE The LUMIBIRD Group recorded revenues of €141.5m for the first 9 months of 2024, up +2% and stable on a like-for-like basis. Revenues for the 3rd quarter showed a clear upturn in growth for the Medical segment, at +8.0%, and stability for the Photonics segment, at +0.2% on a reported basis. The Group also announces the signature of an agreement with Amplitude Laser Group for the acquisition of the Continuum nanosecond laser product line, enabling Lumibird to enhance its range for the scientific markets and strengthen its leadership of the North American market. 👉 Read the full press release: https://lnkd.in/dEAQ7NYS #lumibirdmedical #lumibird #pressrelease

📣 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝘁𝗼 𝘁𝗵𝗲 𝗼𝗽𝗵𝘁𝗵𝗮𝗹𝗺𝗶𝗰 𝘂𝗹𝘁𝗿𝗮𝘀𝗼𝘂𝗻𝗱 𝗲𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝘆 𝗶𝗻 𝗩𝗲𝗻𝗲𝘇𝘂𝗲𝗹𝗮: 𝗗𝗿. 𝗥𝗮𝗳𝗮𝗲𝗹 𝗠𝗼𝗿𝗲𝗻𝗼 𝗮𝗱𝗼𝗽𝘁𝘀 𝗔𝗕𝗦𝗼𝗹𝘂! We are proud to announce that Dr Rafael Moreno, a specialist in ophthalmic imaging, has recently chosen our state-of-the-art ABSOLU ultrasound platform for the Hospital Universitario de Maracaibo in Venezuela. Dr Moreno's expertise in ocular imaging, combined with the precision and innovation of ABSolu, will be the ideal duet to fine-tuning diagnosis of ocular pathologies for patients. Together, we are making a difference to eye care worldwide. 🌍 #LumibirdMedical #OcularImaging #Ophthalmology #ABSOLU

🎧 𝗥𝗘𝗣𝗟𝗔𝗬 - 𝗖𝗼𝗻𝘁𝗿𝗼𝘃𝗲𝗿𝘀𝗶𝗲𝘀 𝗼𝗻 𝗠𝗼𝗱𝗲𝗿𝗻 𝗟𝗮𝘀𝗲𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗥𝗲𝘁𝗶𝗻𝗮 𝗮𝗻𝗱 𝗩𝗶𝘁𝗿𝗲𝗼𝘂𝘀 Some great feedback of our successful EURETINA symposium moderated by Dr Alejandro Filloy Rius with Prof Giuseppe Querques, Prof. Paulo Eduardo Stanga, Dr Marco Lupidi and Dr Kenneth Fong. Lots of attendees willing to know more about the latest advancements in retinal and vitreous diseases laser treatments. In this informative session, leading experts discussed: ◾️ Vitreous Floaters and Opacities: Observation vs intervention ◾️ Subthreshold Laser Therapy: To titrate or not to titrate? 👉 If you did not have the chance to attend this session, take a look at the video: https://lnkd.in/dzE3YjaQ #retinaldiseases #vitreous #lasertreatment #ophthalmology

💦 𝗟𝗮𝘁𝗲𝘀𝘁 𝗥𝗲𝘀𝘂𝗹𝘁𝘀 𝗼𝗻 𝘁𝗵𝗲 𝘂𝘀𝗲 𝗼𝗳 𝗖.𝗦𝗧𝗜𝗠 𝗜𝗣𝗟 At the recent ACOS Congress, Dr Marie-Caroline Trone presented the latest results obtained with C.STIM IPL. This was an excellent opportunity to review her clinical study which demonstrated the efficacy and safety of our C.STIM IPL in the treatment of Meibomian Gland Dysfunction (MGD), the main cause of dry eye disease. Over the course of the study, patients treated with C.Stim® IPL experienced significant improvements in tear film stability, reduced symptoms of dry eye and an overall improvement in quality of life. 💧 𝗞𝗲𝘆 𝗳𝗶𝗻𝗱𝗶𝗻𝗴𝘀: ▪️ Significant improvement in meibomian gland function (meibum quality and expressibility) ▪️ Tear film break-up time (TBUT) significantly increased ▪️ Ocular Surface improvement with reduction of Oxford score ▪️ Patients reported sustained relief for up to 3 months ▪️ No adverse events were observed, confirming the safety profile This innovative light therapy technology offers an effective, non-invasive solution for millions of people worldwide who suffer from dry eye symptoms. With proven results, C.STIM IPL is revolutionising the treatment of dry eye and offering patients the chance for long-lasting relief and improved quality of life. 🔗 Read the full study here: https://lnkd.in/dpGSPGHA #DryEye #CStimIPL #Ophthalmology #LumibirdMedical #DryEyeTreatment

🌍 𝗟𝘂𝗺𝗶𝗯𝗶𝗿𝗱 𝗠𝗲𝗱𝗶𝗰𝗮𝗹: 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗣𝗿𝗼𝘅𝗶𝗺𝗶𝘁𝘆 𝗮𝗻𝗱 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲, 𝗪𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲 At Lumibird Medical, we believe that true innovation comes from staying close to the field and understanding the evolving needs of healthcare professionals. Our commitment to being at the heart of industry developments takes us across the globe in the coming weeks, with participation in three prestigious events: 📅 𝗦𝗣𝗥𝗩 - 𝗦𝗼𝗰𝗶𝗲𝗱𝗮𝗱 𝗣𝗮𝗻𝗮𝗺𝗲𝗿𝗶𝗰𝗮𝗻𝗮 𝗱𝗲 𝗥𝗲𝘁𝗶𝗻𝗮 𝘆 𝗩𝗶𝘁𝗿𝗲𝗼 October 24-27, 2024 - Fort Lauderdale, FL, USA 𝐵𝑜𝑜𝑡ℎ #12 📅 𝗫𝗟𝗩𝗜 𝗜𝗻𝘁𝗲𝗿-𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗖𝗼𝘂𝗿𝘀𝗲 𝗶𝗻 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗢𝗽𝗵𝘁𝗵𝗮𝗹𝗺𝗼𝗹𝗼𝗴𝘆 - 𝗕𝗮𝘀𝗰𝗼𝗺 𝗣𝗮𝗹𝗺𝗲𝗿 𝗘𝘆𝗲 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 October 27-30, 2024 - Miami, FL, USA 𝐵𝑜𝑜𝑡ℎ #508 - 510 📅 𝗥𝗔𝗡𝗭𝗖𝗢 - 𝗥𝗼𝘆𝗮𝗹 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮𝗻 𝗮𝗻𝗱 𝗡𝗲𝘄 𝗭𝗲𝗮𝗹𝗮𝗻𝗱 𝗖𝗼𝗹𝗹𝗲𝗴𝗲 𝗼𝗳 𝗢𝗽𝗵𝘁𝗵𝗮𝗹𝗺𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 November 1-4, 2024- Adelaide, Australia 𝐵𝑜𝑜𝑡ℎ #25 - 28 These events give us the opportunity to connect with you, our valued partners and customers, and to showcase how our cutting-edge ophthalmic solutions are shaped by your needs and feedback. Our presence on the international stage reflects not only our global reach but also our dedication to supporting healthcare professionals everywhere. Let's meet, exchange, and together, drive the future of medical technology forward! #LumibirdMedical #Innovation #Ophthalmology